Key role for Bak activation and Bak-Bax interaction in the apoptotic response to vinblastine

Molecular Cancer Therapeutics

Volumn 7, Issue 7, 2008, Pages 2224-2232

  Upreti, Meenakshi ^a   Chu, Rong ^a   Galitovskaya, Elena ^a   Smart, Sherri K ^a   Chambers, Timothy C ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; VINBLASTINE; PROTEIN BCL X;

APOPTOSIS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG SENSITIVITY; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; ANIMAL; CELL FRACTIONATION; CHEMISTRY; DRUG EFFECT; METABOLISM; MITOCHONDRION; MOUSE; PROTEIN BINDING; PROTEIN QUATERNARY STRUCTURE; PROTEIN TRANSPORT; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CELL LINE, TUMOR; HUMANS; MICE; MITOCHONDRIA; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; PROTEIN TRANSPORT; SUBCELLULAR FRACTIONS; VINBLASTINE;

EID: 51049098535     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-07-2299     Document Type: Article

References (35)

1. Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007;26:1324-7.
2. Walensky LD. Bcl-2 in the crosshairs: tipping the balance of life and death. Cell Death Differ 2006;13:1339-50.
3. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000;6:513-9.
4. Gross A, McDonnell JM, Korsmeyer SJ. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev 1999;13:1899-911.
5. Breckenridge DG, Xue D. Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases. Curr Opin Cell Biol 2004;16:647-52.
6. Willis SN, Fletcher JI, Kaufmann T, et al. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax and Bak. Science 2007;315:856-9.
7. Wei MC, Zong WX, Cheng EH, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001;292:727-30.
8. Youle RJ, Karbowski M. Mitochondrial fission in apoptosis. Nat Rev Mol Cell Biol 2005;6:657-63.
9. Hsu YT, Youle RJ. Nonionic detergents induce dimerization among members of the Bcl-2 family. J Biol Chem 1997;272:13829-34.
10. Wolter KG, Hsu YT, Smith CL, Nechustan A, Xi XG, Youle RJ. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 1997;139:1281-92.
11. Mikhailov V, Mikhailova M, Degenhardt K, Venkatachalam MA, White E, Saikumar P. Association of Bax and Bak homo-oligomers in mitochondria. Bax requirement for Bak reorganization and cytochrome c release. J Biol Chem 2003;278:5367-76.
12. Willis SN, Chen L, Dewson G, et al. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 2005;19:1294-305.
13. Rowinsky EK, Donehower RC. The chemotherapy source book. 2nd ed. Baltimore (MD): Williams and Wilkins; 1998. p. 387-423.
14. Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004;4:253-65.
15. Blagosklonny MV, Fojo T. Molecular effects of paclitaxel: myths and reality (a critical review). Int J Cancer 1999;83:151-6.
16. Wang LG, Liu XM, Kreis W, Budman DR. The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review. Cancer Chemother Pharmacol 1999;44:355-61.
17. Bhalla KN. Microtubule-targeted anticancer agents and apoptosis. Oncogene 2003;22:9075-86.
18. Yamaguchi H, Chen J, Bhalla K, Wang HG. Regulation of Bax activation and apoptotic response to microtubule-damaging agents by p53 transcription-dependent and -independent pathways. J Biol Chem 2004;279:39431-7.
19. Yamaguchi H, Paranawithana SR, Lee MW, Huang Z, Bhalla KN, Wang HG. Epothilone B analogue (BMS-247550)-mediated cytotoxicity through induction of Bax conformational change in human breast cancer cells. Cancer Res 2002;62:466-71.
20. Upreti M, Lyle CS, Skaug B, Du L, Chambers TC. Vinblastine-induced apoptosis is mediated by discrete alterations in subcellular location, oligomeric structure, and activation status of specific Bcl-2 family members. J Biol Chem 2006;281:15941-50.
21. Taguchi T, Kato Y, Baba Y, et al. Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas. Oncol Rep 2004;11:421-6.
22. Longuet M, Serduc R, Riva C. Implication of bax in apoptosis 'depends on microtubule network mobility. Int J Oncol 2004;25:309-17.
23. Salah-Eldin AE, Inoue S, Tsukamoto S, Aoi H, Tsuda M. An association of Bcl-2 phosphorylation and Bax localization with their functions after hyperthermia and paclitaxel treatment. Int J Cancer 2003;103:53-60.
24. Wang GQ, Gastman BR, Weickowski E, et al. A role for mitochondrial Bak in apoptotic response to anticancer drugs. J Biol Chem 2001;276:34307-17.
25. Du L, Lyle CS, Chambers TC. Characterization of vinblastine-induced Bcl-xL and Bcl-2 phosphorylation: evidence for a novel protein kinase and a coordinated phosphorylation/dephosphorylation cycle associated with apoptosis induction. Oncogene 2005;24:107-17.
26. Wei MC, Lindsten T, Mootha VK, et al. tBID, a membrane-targeted deathligand, oligomerizes BAK to release cytochrome c. Genes Dev 2000;14:2060-71.
27. Pagliari LJ, Kuwana T, Bonzon C, et al. The multidomain proapoptotic molecules Bax and Bak are directly activated by heat. Proc Natl Acad Sci U S A 2005;102:17975-80.
28. Ruffolo SC, Shore GC. Bcl-2 selectively interacts with the BID-induced open conformer of BAK, inhibiting BAK auto-oligomerization. J Biol Chem 2003;278:25039-45.
29. Lindsten T, Ross AJ, King A, et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell 2000;6:1389-99.
30. Berry A, Goodwin M, Moran CL, Chambers TC. AP-1 activation and altered AP-1 composition in association with increased phosphorylation and expression of specific Jun and Fos family proteins induced by vinblastine in KB-3 cells. Biochem Pharmacol 2001;62:581-91.
31. Cheng EH, Sheiko TV, Fisher JK, Craigen WJ, Korsmeyer SJ. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 2003;301:513-7.
32. Sundararajan R, Cuconati A, Nelson D, White E. Tumor necrosis factor-α induces Bax-Bak interaction and apoptosis, which is inhibited by adenovirus E1B 19K. J Biol Chem 2001;276:45120-7.
33. Antignani A, Youle RJ. How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane? Curr Opin Biol 2006;18:685-9.
34. Opferman JT. Unraveling Mcl-1 degradation. Cell DeathDiffer 2006;12:1260-2.
35. Degenhardt K, Sundararajan R, Lindsten T, Thompson C, White E. Bax and Bak independently promote cytochrome c release from mitochondria. J Biol Chem 2002;277:14127-34.